Economics of Respiratory Syncytial Virus (RSV) Vaccination in All U.S. Adults≥75 years-old, and Adults aged 60-74 and 50-59 years at Increased Risk : SUMMARY COMPARING MODELS FROM: GSK, Moderna AND University of Michigan-CDC
Public Domain
-
June 26, 2024
File Language:
English
Details
-
Personal Author:
-
Corporate Authors:
-
Description:Evidence to Recommendations Framework (EtR) : RSV Vaccination in Adults Aged 50–59 years, 60–74 years, and 75 years and older
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Pages in Document:20 unnumbered slides
-
Collection(s):
-
Main Document Checksum:urn:sha256:889151168cf2048cb308d5e939844d729d543760fbbbd3a7acea9d1d49e16f00
-
Download URL:
-
File Type:
Related Documents
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like